Altimmune

About:

Altimmune focused on the development of products to stimulate robust and durable immune responses for the prevention.

Website: http://www.altimmune.com/

Top Investors: HealthCap, Novartis Venture Fund, Biomedical Advanced Research and Development Authority (BARDA), Redmont Capital, Truffle Capital

Description:

Altimmune is an emerging biotechnology company located in Montgomery County, MD. Altimmune develops vaccines and other biological products to address unmet market and public health needs. The company uses a proprietary technology for non-invasive intranasal delivery, and has shown proof of principle in animals and in initial human clinical studies. Vaxin Inc., formerly known as Vaxin Pharmaceuticals and ImmuneFocus Corporation, was founded in 1997 by Emerging Technology Partners. Early experiments revealed that DNA incorporated into an adenovirus can elicit an immune response when placed on the surface of the skin, and subsequently research was expanded to include applications on the skin in the nose as well as experimentation with other vectors.